Argon Medical's SuperCore Advantage In Interventional Oncology: The Driving Engine Behind Interventional Oncology Devices Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Interventional Oncology Devices Market Through 2025?
The market for interventional oncology devices has seen a robust expansion in recent times. Its growth trajectory forecasts a swell from $2.39 billion in 2024 to $2.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.3%. The escalation observed in the past owes to an aging demographic, a surge in cancer cases, amplified pharmaceutical R&D spending, increased healthcare expenses, and the proliferation of healthcare facilities.

What's the Projected Size of the Global Interventional Oncology Devices Market by 2029?
The market for interventional oncology devices is predicted to witness robust growth in the coming years. It is projected to escalate to $3.34 billion in 2029 with a compound annual growth rate (CAGR) of 7.3%. Factors contributing to the expansion during the forecast period include an aging population, a rising preference for minimally invasive surgeries (MIS), increased research and development activities, elevated healthcare spending, promising prospects in emerging economies, and a surge in the incidence of cancer and chronic diseases. Key trends for the forecast period encompass prioritizing the development of sophisticated image-guided oncology instruments, leveraging artificial intelligence to invent groundbreaking devices, engineering innovative embolic devices to enhance oncology procedures, emphasizing on utilizing robotics technology, and establishing partnerships with other businesses and research organizations for expediting product innovation and development.

View the full report here:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Top Growth Drivers in the Interventional Oncology Devices Industry: What's Accelerating the Market?
Major players in the interventional oncology devices market are turning their focus on advancements such as tissue volume, which can improve both diagnostic precision and treatment success in oncology procedures. The term 'tissue volume' relates to the quantity of biological tissue gathered during biopsy. Larger volumes of tissue deliver more inclusive samples, thereby enhancing diagnostic accuracy and treatment plan effectiveness. Take for example, Argon Medical, a medical device firm based in the US. It introduced the SuperCore Advantage semi-automatic biopsy in June 2023. The SuperCore Advantage has the capacity to gather up to 35% more samples compared to its top competitors, reducing the necessity for multiple biopsy passes. This aspect is vital for securing sufficient tissue samples for accurate diagnosis.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Trends Will Shape the Interventional Oncology Devices Market Through 2029 and Beyond?
Leading businesses are emphasizing the implementation of robotic technology in interventional oncology devices to increase performance. The robotic framework consolidates image-led planning and navigation with the insertion of various tools into the intended body part with enhanced precision and effectiveness. For example, Quantum Surgical's Epione interventional oncology robotics platform received approval from the U.S. Food and Drug Administration in March 2022.

What Are the Main Segments in the Interventional Oncology Devices Market?
The interventional oncology devices market covered in this report is segmented -

1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Which Top Companies are Driving Growth in the Interventional Oncology Devices Market?
Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

Which Regions Will Dominate the Interventional Oncology Devices Market Through 2029?
North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3304

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.